National Drug Policy New Zealand

The National Drug Policy aims to improve the health and wellbeing of New Zealanders by encouraging the development of action plans and programmes that prevent and reduce drug-related harm.

Progress under the National Drug Policy is reviewed twice yearly by the Ministerial Committee on Drug Policy (MCDP). Initiatives are progressed and monitored by a group of government agencies that make up the Inter-Agency Committee on Drugs (IACD).

This website provides information and updates relating to drug policy; the work of committees that have key roles in relation to policy and classification; and information about specific drugs.

News and Updates

25 July: Research into knowledge and attitudes to illegal drugs in New Zealand
A study among the general public and people with experience of illegal drug use

8 Apr: Costs of Harmful Alcohol and Other Drug Use
A report from Business and Economic Research Limited (BERL)

5 Mar: 2008 Tobacco Returns
Annual Tobacco Returns filed by manufacturers and importers pursuant to section 35 of the Smoke-free Environments Act 1990.

4 Mar: Ready-to-Drink Beverages - Policy Paper
This paper was developed in response to concerns regarding ready-to-drink beverages and assesses the evidence and implications of a selection of potential policy options targeted at ready-to-drink beverages.

11 Dec:Systematic review of the literature on Fetal Alcohol Spectrum Disorders (FASD)
This review of the literature on Fetal Alcohol Spectrum Disorders (FASD) evaluates the relative effectiveness of various prevention strategies aimed at reducing the burden of FASD.

9 Oct: Prescription Drug Misuse: Issues for Primary Care
This report provides an insight into prescription drug misuse in New Zealand through the eyes of primary healthcare practitioners and experts in drug policy and treatment.

View older news and updates.

Page last updated: 25 July 2009